Public Health Committee

JOINT FAVORABLE REPORT

Bill No.:

SB-998

Title:

AN ACT CONCERNING PRESCRIPTION DRUGS.

Vote Date:

3/23/2015

Vote Action:

Joint Favorable

PH Date:

3/18/2015

File No.:

495

SPONSORS OF BILL:

Public Health Care

REASONS FOR BILL:

This bill prohibits anyone from knowingly dispensing or importing or reimporting into the state a counterfeit drug or device. It subjects violators to a maximum criminal fine of $10,000, one year imprisonment, or both, for each violation. It also allows the DCP commissioner to take various disciplinary actions, including a $1,000 civil penalty or license suspension or revocation.

The bill also provides that any prescribing practitioner who takes these actions, or who knowingly purchases for resale, sells, offers for sale, or delivers a counterfeit drug or device, is subject to the standard array of DPH disciplinary actions.

RESPONSE FROM ADMINISTRATION/AGENCY:

None

NATURE AND SOURCES OF SUPPORT:

Allergan: This bill is in particular concern to Allergan. Black Market drugs, or in this case the distribution and sale of counterfeit and illegal imported prescription drugs, have become an issue in Connecticut. With the growth of healthcare costs, we are witnessing a dramatic increase in the amount fraudulent prescription drugs and medical devices being sold across the country. We have also seen a dramatic increase in the importation of drugs from foreign nations. To ensure patient safety and to fight the scourge associated with counterfeit/black market drugs, it is imperative that the State of Connecticut proactively and forcefully adjudicates those entities, which are facilitating this illegal activity.

NATURE AND SOURCES OF OPPOSITION:

None

Reported by: Zani Imetovski

Date: 4/10/2015